Contents
01
Streamline your drug development pathway from preclinic to FIH/POC
02
Introducing SGS PACE
Streamline your drug development pathway from preclinic to FIH/POC
No matter the industry, collaborations between multiple parties throughout a project pipeline can prove challenging.
In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) poses potential hurdles for companies – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimization and clinical trials.
At SGS, we have implemented a dedicated program management solution – SGS PACE – to ensure seamless operations and streamlined communication through a single point of contact. A dedicated program manager will work in collaboration with your teams and SGS’s experts to provide custom strategies, time frames and cost management to match your needs and budget.
What is SGS PACE?
SGS PACE – (Product Accelerated Clinically Enabled) – is a unique, streamlined pathway from preclinical to First-In-Human (FIH) and Proof-Of-Concept (POC).
This bespoke pathway is built to overcome the current challenges of working with different CDMOs and CROs by bringing together drug development consultancy, bioanalysis, formulation and manufacturing, and clinical research services into one helpful service.
Usually, biotech and pharmaceutical companies must find different CDMO and CRO partners throughout the pipeline, managing lots of different parties and spending lots of time on communication and knowledge-sharing, while escalating any potential unforeseen issues.
Instead, SGS takes ownership through the SGS PACE service by providing clients with access to all of these services through one partner and one dedicated point of contact throughout the entire process. SGS PACE removes the challenge of conflicting timelines from different vendors, along with cascading delays, resulting in a more agile, resilient process.
Your program at your own budget and pace.
SGS PACE offers improved efficiency, helping to speed up the clinical development process through a single point of contact for all your formulation and early development needs.
Doctor Jelle Klein, Medical Director at our Clinical Pharmacology Unit in Belgium
Register for free content
Access the full SGS PACE factsheet to discover how this service offers a streamlined pathway for molecules from clinical formulation to First in Human (FIH) and Proof of Concept (POC).
